狼疮性肾炎
封锁
医学
补体系统
肾炎
免疫学
系统性红斑狼疮
肾
抗体
蛋白酵素
炎症
药理学
癌症研究
替代补体途径
肾脏疾病
免疫系统
CD8型
肾小球肾炎
受体
凝集素途径
转录组
急性肾损伤
单克隆抗体
补语(音乐)
作者
Tianqi Tu,Chuqiao Wang,Zhong Li,Wenyan Fu,Ying Cong Ryan Shea Tan,Ming‐Hui Zhao
摘要
Lupus nephritis (LN) is a major cause of organ damage in systemic lupus erythematosus and is driven in part by overactivation of the lectin pathway (LP) and alternative pathway (AP) of complement. Mannan-binding lectin-associated serine protease-2 (MASP-2) initiates LP through C4/C2 cleavage, whereas MASP-3 enables AP amplification by activating pro-factor D. We hypothesized that concurrent inhibition of both proteases would provide superior renoprotection compared with single-pathway blockade in established disease. Female BALB/c mice with pristane-induced LN received anti-MASP-2, anti-MASP-3, bispecific antibodies, or vehicle for 4 weeks. Bispecific MASP-2/3 inhibition produced greater improvements in albuminuria, renal activity index, and glomerular C3d and C5b-9 deposition than either monotherapy. Functional assays confirmed selective LP suppression with MASP-2 blockade and AP suppression with MASP-3 blockade, whereas dual inhibition maximally reduced both pathways and their downstream complement effectors. Kidney transcriptomics demonstrated broad down-regulation of complement, coagulation, and inflammatory gene networks. Together, these findings indicate that bispecific MASP-2/3 blockade provides robust complement-directed protection in established LN and may represent an effective therapeutic strategy for complement-mediated kidney disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI